Viral vector gene therapy represents a rapidly advancing field at the intersection of molecular medicine, biotechnology, and clinical translation. Viral ...

Seoul National University (SNU) is launching the ‘SNU Grand Quest’ initiative, investing approximately 1 billion Korean won ...

The world’s largest professional psychiatry organization is preparing for the day when biological indicators can help ...

Sarah Guo, founder of the AI-focused VC firm Conviction and co-host of the No Priors podcast (which has a YouTube channel ...

AusBiotech welcomes today's release of Ambitious Australia: Strategic Examination of Research and Development Final Report, which calls for urgent action to strengthen Australia's research, ...

Medicine shortages, European health sovereignty, the ethical lines of AI, and mental health dominated the conversation ...

Tonix Pharma Q4 earnings: revenue up 109% on early Tonmya launch, but losses persist. Click here to read my most recent ...

Biotechnology research continues to attract attention within broader healthcare discussions. Institutional participation ...

Market focus on Biogen reflects ongoing developments in neurological therapy pipelines. Portfolio adjustments and coverage updates continue to shape visibility of the biotechnology company. The ...

Biotech stocks returned up to 36% in 2025, while longevity investing hit $8.5B in funding. Here’s the data individual investors should know.